Houston,

Texas

and

Tuebingen,

related search terms

Category: All Stories / News

Sort by

Release date

Category

All

From

To

Language

All

Inactive stories

show

Content types

Company

Newsrooms

Hovmand A/S

Albert Handtmann Metallgusswerk GmbH & Co. KG

Forum Gesundheitsstandort BW

MEW Mittelständische Energiewirtschaft Deutschland e.V.

Handheld Germany GmbH

immatics biotechnologies GmbH 10/04/2017

Immatics Receives $58 Million in Financing to Develop T-Cell Receptor Based Immunotherapies

Immatics, a leading company in the field of cancer immunotherapy, today announced the completion of its Series E financi…

Finance / Balance Sheets

immatics biotechnologies GmbH 09/28/2017

Immatics Initiates the First Phase I Clinical Trial of its Unique ACTengine® Approach in Patients with Advanced Solid Cancers

Immatics, a leading company in the field of cancer immunotherapy, today announced that it has initiated enrollment of pa…

Research / Development

immatics biotechnologies GmbH 08/21/2017

Immatics Initiates Personalized Adoptive Cellular Therapy in Patients with Relapsed And/Or Refractory Solid Cancers Using Its Pioneering Target Warehouse

Immatics, a leading company in the field of cancer immunotherapy, today announced that it has initiated enrollment of pa…

Research / Development

immatics biotechnologies GmbH 01/08/2016

Immatics appoints Katina Dorton as Chief Financial Officer

Immatics Biotechnologies GmbH, a leading company in the field of cancer immunotherapy announces the appointment of Katin…

Company-internal

1
2
3
4 (current page)

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.

Publish

Would you like to publish your story free of charge? Simply leave the posting and checking to our service team!

Subscribe

Get relevant information and the PresseBox newsletter in your mailbox!

The publisher indicated in each case (see company info by clicking on image/title or company info in the right-hand column) is solely responsible for the stories above, the event or job offer shown and for the image and audio material displayed. As a rule, the publisher is also the author of the texts and the attached image, audio and information material. The use of information published here is generally free of charge for personal information and editorial processing. Please clarify any copyright issues with the stated publisher before further use. In case of publication, please send a specimen copy to service@pressebox.de.

You will also receive a separate filtered feed for each category of PresseBox. Additionally, in each newsroom you will find a subscribe button with further individual RSS feeds. There is also a corresponding Facebook page for each category.

Select a category to view the associated URL.

Category

All

RSS